Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial
Author:
Publisher
Elsevier BV
Subject
Neurology (clinical)
Reference35 articles.
1. Is a separate monotherapy indication warranted for antiepileptic drugs?;Mintzer;Lancet Neurol,2015
2. The pharmacological treatment of epilepsy in adults;Perucca;Lancet Neurol,2011
3. Current understanding of the mechanism of action of the antiepileptic drug lacosamide;Rogawski;Epilepsy Res,2015
4. Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures;Ben-Menachem;Epilepsia,2007
5. Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial;Chung;Epilepsia,2010
Cited by 135 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Switching carbamazepine to lacosamide improves gamma‐glutamyl transpeptidase levels;Epilepsia Open;2024-08-14
2. Efficacy, safety, and tolerability of adjunctive Lacosamide therapy for focal seizures in young children aged ≥1 month to ≤4 years: A real‐world study;CNS Neuroscience & Therapeutics;2024-08
3. Cardiac adverse events associated with lacosamide: a disproportionality analysis of the FAERS database;Scientific Reports;2024-07-13
4. Synthesis, Molecular Docking, and Anticonvulsant Activity of 1,3,4-Oxadiazole Derivatives;Journal of Health and Allied Sciences NU;2024-06-18
5. Effectiveness and safety of Lacosamide in pediatric patients with epilepsy under four years: Results from a prospective cohort study in China;Seizure: European Journal of Epilepsy;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3